Project documents | Quizartinib for treating relapsed or refractory acute myeloid leukaemia [ID1325] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 218 KB)

Published:

09 November 2018
Final stakeholder list (PDF 260 KB)

Published:

09 November 2018
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 260 KB)

Published:

09 November 2018
Equality impact assessment (Scoping) (PDF 175 KB)

Published:

09 November 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (MSWord 87 KB)

Published:

04 July 2018
Draft scope post referral (PDF 315 KB)

Published:

04 July 2018